Science
Mechanism of Action
Oligopeptide-53 precisely targets and inhibits the activity of three critical enzymes in the melanogenesis pathway: tyrosinase, TRP-1, and TRP-2. This concerted action effectively diminishes the synthesis of melanin, leading to a measurable reduction in existing hyperpigmentation and aiding in the prevention of future discoloration.
Research
Clinical Evidence
Low confidenceN/A
Transparency
Dusting Analysis
The Formula
Formulation
Stability
Oligopeptide-53 exhibits optimal stability within a neutral pH range of 5.5 to 7.5. For precise formulation and to maintain efficacy, it must be incorporated into water-based systems during the cooling phase, specifically when temperatures are below 40°C. Recommended storage is between 2–8°C, diligently protected from both light and heat.
Safety
Safety Profile
Specific regulatory assessments from CIR, SCCS, or FDA for Oligopeptide-53 (CG-Nospotin) are not currently available, with existing data noted as insufficient. However, oligopeptides as a class are generally well-tolerated by the skin and typically do not induce irritation.
Your Skin
Skin Compatibility
Our Assessment
Verdict
Oligopeptide-53 demonstrates a clear mechanism for reducing hyperpigmentation through melanin inhibition; however, comprehensive clinical efficacy data and specific usage concentrations are currently insufficient for a full evaluation.
Related
Similar Ingredients
Finding similar ingredients…
References
Sources